SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-062039
Filing Date
2011-11-08
Accepted
2011-11-08 16:15:53
Documents
12
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v239326_10q.htm 10-Q 686274
2 EXHIBIT 10.1 v239326_ex10-1.htm EX-10.1 15753
3 EXHIBIT 31.1 v239326_ex31-1.htm EX-31.1 13036
4 EXHIBIT 31.2 v239326_ex31-2.htm EX-31.2 11202
5 EXHIBIT 32.1 v239326_ex32-1.htm EX-32.1 5899
6 EXHIBIT 32.2 v239326_ex32-2.htm EX-32.2 5460
  Complete submission text file 0001144204-11-062039.txt   2217514

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nvax-20110930.xml EX-101.INS 251277
8 XBRL TAXONOMY EXTENSION SCHEMA nvax-20110930.xsd EX-101.SCH 12655
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20110930_cal.xml EX-101.CAL 35329
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20110930_def.xml EX-101.DEF 77695
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20110930_lab.xml EX-101.LAB 81829
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20110930_pre.xml EX-101.PRE 84607
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 111188018
SIC: 2836 Biological Products, (No Diagnostic Substances)